Delivery Order SPE2DB20D3103-SPE2DB23FN9K7
Award Date 7/10/23
Potential Completion Date 7/11/23
Potential Value $288
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $753.72 firm fixed price delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The syringes will be delivered to a location in Conshohocken, Pennsylvania by July 21, 2023 under the terms of the contract. The Defense Logistics Agency utilizes such contracts to procure pharmaceuticals and medical supplies in support of the U.S. Department of Defense's healthcare...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $269.74 delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The firm fixed price order is for product delivery by July 10, 2023 with performance taking place in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The Defense Logistics Agency utilizes naloxone to support treatment of opioid overdoses as part of...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $135,000 delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on September 11, 2023. No set aside designation or subcontracting details were included. The Defense Logistics Agency routinely procures pharmaceutical and medical...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $463,840 delivery order by the Defense Logistics Agency to provide 2 mg/2 ml syringes of naloxone. The firm fixed price order is for performance from August 22-23, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to support the...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $450,560 firm fixed price delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The syringes will be delivered to a location in Conshohocken, Pennsylvania within a one day period from July 20-21, 2023. The Defense Logistics Agency issues contracts and delivery orders in support of the various military service branches to ensure critical medical supplies and...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $289.38 delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania and will support DLA's medical countermeasures procurement programs. No subcontractors or set aside designations were indicated. Amerisourcebergen will deliver the naloxone syringes from its corporate...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $25,860 firm fixed price delivery order by the Defense Logistics Agency to provide 0.4 mg/ml vials of naloxone for use through August 30, 2023. Performance will take place in Conshohocken, Pennsylvania under the DLA's pharmaceuticals and medical supplies indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set-aside designations were identified in the award information....
- The Defense Logistics Agency Troop Support Medical awarded a $698.39 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 2 mg/2 ml syringes of naloxone. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corp, will perform the contract from its location in Conshohocken, Pennsylvania between June 22nd and 23rd, 2023. The delivery order was issued under an existing DLA medical vehicle and has no set aside designation....
- The Defense Logistics Agency awarded a $1,102 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 milligram/2 milliliter naloxone syringes. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location to supply the antidote medications to the DLA. No major subcontractors or set aside designations were identified. This award is likely associated with the DLA's stockpile...
- The Defense Logistics Agency Troop Support Medical awarded a $278,630 delivery order to Amerisourcebergen Drug Corporation for 2 mg/2 ml syringes of naloxone. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between September 14-15, 2023. Amerisourcebergen will supply the naloxone syringes in support of the Defense Logistics Agency's medical countermeasures program. No subcontractors or set aside designations were identified. The delivery order was...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN9K7Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $287.50 firm fixed price delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The syringes will be delivered to a location in Conshohocken, Pennsylvania by July 11, 2023 under the terms of this single award. As the DLA supports medical readiness for the Department of Defense, this contract for opioid overdose reversal medication indicates its use for service member health programs. No set aside designation or subcontractors were identified in the award information.
Generated 12/18/23, 4:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $288 | 7/10/23 |